These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 38940326

  • 1. Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review).
    Li H, Li X, Du W.
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.
    Xin Y, Wang X, Meng K, Ni C, Lv Z, Guan D.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31763681
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J, Xiang J.
    Mol Cancer; 2019 Mar 13; 18(1):40. PubMed ID: 30866952
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS, Ma S, Dou H, Liu F, Zhang SY, Jiang C, Xiao M, Huang YX.
    Exp Cell Res; 2020 Jun 15; 391(2):111983. PubMed ID: 32268136
    [Abstract] [Full Text] [Related]

  • 9. Exosomal microRNA: a novel biomarker for breast cancer.
    He Y, Deng F, Yang S, Wang D, Chen X, Zhong S, Zhao J, Tang J.
    Biomark Med; 2018 Feb 15; 12(2):177-188. PubMed ID: 29151358
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM, Tao W, Li JC, Zhu DM, Miao Y.
    Eur Rev Med Pharmacol Sci; 2019 Dec 15; 23(23):10422-10432. PubMed ID: 31841196
    [Abstract] [Full Text] [Related]

  • 11. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
    Rahmani F, Tadayyon Tabrizi A, Hashemian P, Alijannejad S, Rahdar HA, Ferns GA, Hassanian SM, Shahidsales S, Avan A.
    Gene; 2020 Sep 05; 754():144892. PubMed ID: 32534060
    [Abstract] [Full Text] [Related]

  • 12. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
    Shan G, Zhou X, Gu J, Zhou D, Cheng W, Wu H, Wang Y, Tang T, Wang X.
    Cell Oncol (Dordr); 2021 Feb 05; 44(1):45-59. PubMed ID: 33423167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway.
    Liang Z, Liu L, Gao R, Che C, Yang G.
    Cell Mol Biol Lett; 2022 Oct 09; 27(1):88. PubMed ID: 36210461
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exploring signaling pathway crosstalk in glioma by mapping miRNA and WNT pathways: A review.
    Isa AI.
    Int J Biol Macromol; 2024 Feb 09; 257(Pt 2):128722. PubMed ID: 38092099
    [Abstract] [Full Text] [Related]

  • 18. Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
    Zhang X, Bai J, Yin H, Long L, Zheng Z, Wang Q, Chen F, Yu X, Zhou Y.
    Mol Oncol; 2020 Oct 09; 14(10):2589-2608. PubMed ID: 32679610
    [Abstract] [Full Text] [Related]

  • 19. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H.
    Oncol Res Treat; 2017 Oct 09; 40(7-8):423-429. PubMed ID: 28683441
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.